barbara.lempert
WASHINGTON, May 23, 2013 (AP) — The Food and Drug Administration said Thursday it approved a new blood test from Roche to help doctors diagnose diabetes.
The Cobas ...
barbara.lempert
Type 2 Diabetes in Youth Progresses Faster, More Aggressively Than in Adults, Even Under Optimal Treatment Conditions
TODAY Study Finds Quickly Progressing Co-Morbidities, ...
Eric Palmer
Novartis has grabbed one of two new indications it was shooting for with its rare disease drug Ilaris, one step toward turning the drug into a blockbuster.
FiercePharma ...
John Carroll
Yesterday Merck's top executives spent a considerable amount of time trying to reassure analysts that the Big Pharma company is actively engaged in the hunt for new ...
John Carroll
Jockeying for a leading position in the high-stakes race to develop a new generation of blockbuster diabetes drugs, Merck ($ MRK) is hitching a ride with Pfizer’s ...
Ryan McBride
The German biotech Evotec and Johnson & Johnson ($ JNJ) have the inside track on drug development based on a Harvard lab's discovery of a hormone that spurs replication ...
Tracy Staton
In established markets, Big Pharma targets doctors to boost sales. In emerging markets, drugmakers train them. Directly. Several of the globe's biggest pharma companies ...
Ryan McBride
Eli Lilly ($ LLY) has added to a body of positive Phase III data for its once-weekly GLP-1 candidate dulaglutide, with two more late-stage studies that have met their ...